Avalo Therapeutics Inc (AVTX) valuation · rev $59.0K
Avalo Therapeutics Inc (AVTX) rev $59.0K.
| Metric | Value |
|---|---|
| Market cap | $51.5M |
| Revenue | $59.0K |
| P/S | 873.5 |
AVTX valuation FAQ
What is AVTX's market cap?
Avalo Therapeutics Inc (AVTX) market cap is $51.5M on the latest cached fundamentals snapshot.
What is AVTX's latest revenue?
Latest cached Avalo Therapeutics Inc (AVTX) revenue was $59.0K. Statements: https://lician.com/financials/avtx
What is AVTX's price-to-sales ratio?
Avalo Therapeutics Inc (AVTX) price-to-sales (P/S) is 873.5, cached market cap $51.5M divided by revenue $59.0K.
How many AVTX valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Avalo Therapeutics Inc (AVTX): Market cap, Revenue, and P/S.
Where is AVTX valuation listed?
Cached valuation multiples for Avalo Therapeutics Inc (AVTX) are listed at https://lician.com/valuation/avtx.
Not investment advice. Cached rows, not a live tape.